Associated Papers
The impacts of natural product miltirone and the CYP2D6 pharmacogenetic phenotype on fluoxetine metabolism.
Zhang X et al.
Frontiers in Pharmacology, 2024
Effects of CYP2D6 Genetic Polymorphism and Drug Interaction on the Metabolism of Dacomitinib.
Han M et al.
Chemical Research in Toxicology, 2022
In vitro assessment of 24 CYP2D6 allelic isoforms on the metabolism of methadone.
Su Y et al.
Drug Testing and Analysis, 2017
Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
Fang P et al.
Drug Design, Development and Therapy, 2017
Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
Hu X et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2016
Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen.
Hu XX et al.
The Journal of Pharmacy and Pharmacology, 2016
Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro.
Hu XX et al.
Drug Metabolism and Pharmacokinetics, 2016
Effect of CYP2D6 variants on venlafaxine metabolism in vitro.
Zhan YY et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2016
Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine.
Xu RA et al.
Drug Design, Development and Therapy, 2016
Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.
Wang Z et al.
Drug Design, Development and Therapy, 2016
Effects of 24 CYP2D6 Variants Found in the Chinese Population on the Metabolism of Risperidone.
Wang ZH et al.
Pharmacology, 2015
Select a paper to view details